- Markets were relatively subdued yesterday as investors focused on comments from Central Bank leaders at the ECB forum in Portugal.
- GSK yesterday announced the completion of the $2.0bn (£1.6bn) acquisition of Canadian biopharmaceutical company Bellus, first announced in mid-April.
- Longer-dated sovereign bond yields fell slightly yesterday.